BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31994704)

  • 1. Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data.
    Huh K; Chung DR; Ha YE; Ko JH; Kim SH; Kim MJ; Huh HJ; Lee NY; Cho SY; Kang CI; Peck KR; Song JH;
    Clin Infect Dis; 2020 Dec; 71(9):e487-e496. PubMed ID: 31994704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
    Kadri SS; Adjemian J; Lai YL; Spaulding AB; Ricotta E; Prevots DR; Palmore TN; Rhee C; Klompas M; Dekker JP; Powers JH; Suffredini AF; Hooper DC; Fridkin S; Danner RL;
    Clin Infect Dis; 2018 Nov; 67(12):1803-1814. PubMed ID: 30052813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult-to-treat resistant gram-negative blood stream infections - the beginning of a superbug era - a prospective observational study.
    P N; Kumar D; Meena DS; R NT; Bohra GK; Tak V; Sharma A; Midha NK; Garg MK
    Indian J Med Microbiol; 2023; 44():100364. PubMed ID: 37356828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
    Cosentino F; Viale P; Giannella M
    Curr Opin Infect Dis; 2023 Dec; 36(6):564-571. PubMed ID: 37930070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.
    Strich JR; Warner S; Lai YL; Demirkale CY; Powers JH; Danner RL; Kadri SS
    Lancet Infect Dis; 2020 Oct; 20(10):1172-1181. PubMed ID: 32505231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
    Jarlier V; Diaz Högberg L; Heuer OE; Campos J; Eckmanns T; Giske CG; Grundmann H; Johnson AP; Kahlmeter G; Monen J; Pantosti A; Rossolini GM; van de Sande-Bruinsma N; Vatopoulos A; Żabicka D; Žemličková H; Monnet DL; Simonsen GS;
    Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.
    Giannella M; Bussini L; Pascale R; Bartoletti M; Malagrinò M; Pancaldi L; Toschi A; Ferraro G; Marconi L; Ambretti S; Lewis R; Viale P
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz505. PubMed ID: 31858018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan.
    Kosai K; Yamagishi Y; Hashinaga K; Nakajima K; Mikamo H; Hiramatsu K; Takesue Y; Yanagihara K
    J Infect Chemother; 2020 Mar; 26(3):193-198. PubMed ID: 31932213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
    Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of epidemiology and antimicrobial resistance of gram-negative bacterial bloodstream infections in children].
    Dong L; Zhang XY; Li CC; Li Z; Xia YQ
    Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):683-688. PubMed ID: 28881515
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC; Wu PF; Lin YT; Wang FD
    J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.
    Sahm DF; Critchley IA; Kelly LJ; Karlowsky JA; Mayfield DC; Thornsberry C; Mauriz YR; Kahn J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features.
    Leal HF; Azevedo J; Silva GEO; Amorim AML; de Roma LRC; Arraes ACP; Gouveia EL; Reis MG; Mendes AV; de Oliveira Silva M; Barberino MG; Martins IS; Reis JN
    BMC Infect Dis; 2019 Jul; 19(1):609. PubMed ID: 31296179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2005 Feb; 49(2):760-6. PubMed ID: 15673761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
    Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
    J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.